rich emollient used in the management of eczema, psoriasis and other dry skin conditions.


A new report written by Professor Richard Sullivan from Kings College London claims that it is only worth spending money on cancer treatments if it is guaranteed that the patient will last at least a year.

Critics are outraged as many cases have been documented where the patients were expected to last weeks but instead survived years following experimental treatment.

The report suggests that there is “little evidence that new drugs help patients” however some people question how this will help patients with rare cancers as new drugs are often the only option.

What do you think? In our current economic climate should we be cost cutting on those that may be beyond saving or should everyone get a fair chance to treatment that could increase their life or at least the quality of their life?

For more information on this story click here



This is the talkhealth blog spot, where we post on a wide range of health conditions, topics, issues and concerns. We post when we see something that we believe is of interest to our vistiors. Our posts do not reflect any particular view or stand point of talkhealth, but are merely to raise attention and awareness.

Add a comment

Your email address will not be published. Required fields are marked *